Arax Advisory Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-89
Closed -$10.3K 1456
2023
Q3
$10.3K Buy
89
+30
+51% +$3.47K ﹤0.01% 713
2023
Q2
$6.07K Buy
59
+14
+31% +$1.44K ﹤0.01% 821
2023
Q1
$4.91K Sell
45
-2
-4% -$218 ﹤0.01% 853
2022
Q4
$5.35K Buy
47
+31
+194% +$3.53K ﹤0.01% 782
2022
Q3
$1K Sell
16
-9
-36% -$563 ﹤0.01% 1204
2022
Q2
$2K Sell
25
-21
-46% -$1.68K ﹤0.01% 992
2022
Q1
$5K Buy
46
+39
+557% +$4.24K ﹤0.01% 807
2021
Q4
$1K Hold
7
﹤0.01% 1134
2021
Q3
$1K Buy
+7
New +$1K ﹤0.01% 982